awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-001FE83A-A5F5-45BC-A235-7928DE18122B
Q42720284-001FE83A-A5F5-45BC-A235-7928DE18122B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-001FE83A-A5F5-45BC-A235-7928DE18122B
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P433
Q42720284-001FE83A-A5F5-45BC-A235-7928DE18122B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-001FE83A-A5F5-45BC-A235-7928DE18122B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2de794169a8f7bb04f7552c33bb22286fcc60dfa
P433
20
http://www.w3.org/2001/XMLSchema#string